|
Straumann Holding AG / Key word(s): Acquisition/Miscellaneous 21-Sep-2023 / 19:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.
Basel, September 21, 2023: The Straumann Group has signed an agreement to acquire AlliedStar, an intraoral scanner (IOS) manufacturer in China. It will enable the Group to offer customers in China a competitive intraoral scanner solution and to address additional price-sensitive markets and customer segments in the future. As part of the Straumann Group, AlliedStar will continue to serve existing channels.
Straumann Group Chief Executive Officer, Guillaume Daniellot, explained: “We are very excited about this acquisition which is fully in line with our strategy to become a digitally-powered oral care company globally. As the entry point for the digital workflow, the IOS is instrumental for the connection to our digital platform which will support our service-led business model. The acquisition will allow us to offer a competitive intraoral scanner solution in China. We are very happy to welcome the AlliedStar team to the Straumann Group which is sharing the mindset of building entrepreneurial businesses with customer centricity in mind”.
As previously communicated, Straumann Group is currently building its “Straumann AXS” digital platform which will connect various services to support a seamless integration between the different solutions, eliminating the need for entering patient data manually in different systems along the treatment journey. The AlliedStar scanner portfolio is going to be seamlessly connected to the Straumann AXS platform which will be launched in the Asia Pacific region in 2024.
AlliedStar founder, Wang Guijian said: “These are very exciting times. Having built this system over the last four years, from idea to execution with a team that put its heart into this, it’s more than rewarding to have found a strong partner with the same values that will help bring our solution to the next level by building a digital platform which can ultimately be offered to customers. The combination of our solution with Straumann Group, a market leader with an extensive network and production expertise, creates a perfect partnership for a high growth expansion.”
AlliedStar has been founded in 2019 by Wang Guijian, an expert in the technology space with over a decade of experience.
The Group will acquire full ownership of AlliedStar spread over several installments over the next eight years. The closing to obtain a controlling stake is expected in the coming months. The parties agreed not to disclose the financial details. About AlliedStar AlliedStar is a pioneering company in the field of digital dentistry, specializing in offering scanning and CAD/CAM solutions to dental clinics. It is at the forefront of transforming the dental industry by concentrating on intraoral scanners and digital dental ecosystems. AlliedStar is committed to enhancing people’s lives by delivering cutting-edge solutions to dental professionals. With its headquarters and R&D center located in Shanghai, and manufacturing facility in the China Dental Valley, AlliedStar works in conjunction with ecological partners to provide comprehensive digital solutions and services to over 90 countries globally.
About Straumann Group The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.
Headquartered in Basel, Switzerland, the Group currently employs more than 10’500 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.
Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland Phone: +41 (0)61 965 11 11 Homepage: www.straumann-group.com
Contacts:
# # # End of Inside Information |
Hepalys to develop Inventiva’s NASH treatment; Everest licenses Kezar’s autoimmune drug
Hepalys Pharma said Thursday it will develop and commercialize Inventiva’s nonalcoholic steatohepatitis (NASH) treatment in Japan and South Korea, paying $10 million upfront and up
September 22, 2023